SK Life Science Leverages Smart, Efficient Solutions Across its Engaged Industry-Leading Sales Team
When SK Life Science began, it tapped into healthcare providers, patients, and scientists to ensure it was relentlessly focused on medical solutions to help drive success in treating central nervous system disorders.
Since then, one of the company’s many achievements has been to expand its commercial organisation to market a prescription medicine used to treat partial-onset seizures in adults, and to help support future innovations that enable its field sales force to efficiently and effectively give medical professionals and patients access to life-improving care.
To support its ongoing growth, SK Life Science partnered with Axtria, an award-winning cloud software and data analytics provider that helps life sciences enterprises gain a competitive edge, move from insights to action, and drive business growth.
Specifically, SK Life Science is leveraging Axtria’s sales planning and operations solution, Axtria SalesIQ, to support an industry-leading, effective, and motivated sales team. Equally important, the company is now making data-driven decisions in call planning and incentive compensation programmes, critical components in creating a field sales force aligned with company goals and objectives.
Life sciences is a hyper-competitive industry continuously racing to discover and commercialise new treatments while strategically engaging with those who can bring those treatments to patients.
“Like most companies, we need to be responsible stewards of our resources,” said Richard Ciorra, Vice President of Commercial Operations at SK Life Science. “We need to maximise those we have to support and engage our sales force in a way that is efficient and meets their evolving needs. With Axtria as a partner, we have used Axtria SalesIQ to create and manage rigorous processes and automate workflows to help our sales employees feel valued and engaged.”
Two of the benefits Richard says SK Life Science gains from the partnership are flexibility and agility.
“When building out our sales operations capabilities, we needed solutions that multiple vendor partners were unable or unwilling to support, but Axtria stepped up to meet these needs,” Richard said. “Our commitment to continuous improvement has us focused on improving our processes. Axtria has been our most valuable partner in support of this. They act as an extension of my team and bring the same sense of urgency to our business that SK Life Science does, making us great partners.”
Richard added that Axtria Sales IQ operates atop the company’s existing customer relationship management system “through a seamless integration.”
“It facilitates smooth trimester processes and gives us great flexibility,” he said. “Our field force knows what needs to get done and has the tools and information to facilitate real-time and period-based changes to territories, from HCP alignments to call-plan updates.”
Through its partnership with Axtria, SK Life Science knows it can count on its partners to support their business in such a way that it decreases the time required to implement changes, ensuring quality and alignment with business objectives every step of the way.
In short, SK Life Science has found that using innovative tools, technologies, and insights from strategic partners can help drive a more connected and efficient field force.
“There’s a reason we’ve been working with Axtria and its Axtria SalesIQ solution for more than four years,” said Richard. “Axtria successfully makes the lines between our teams invisible. We’re focused on the same goals and metrics and, at the end of the day, that’s a great thing to be a part of.”
About SK Life Science
SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals, is committed to accelerating the development of innovative treatments for central nervous system (CNS) disorders and oncology. Both companies are a part of SK Group, one of the largest conglomerates in Korea, a global leader in energy, chemical, semiconductor and telecommunications industries, and one of TIME’s 100 Most Influential Companies of 2023. SK Life Science, Inc., is headquartered in Paramus, New Jersey. SK Life Science and SK Biopharmaceuticals have eight compounds in development globally for the treatment of CNS disorders including epilepsy, attention-deficit hyperactivity disorder, schizophrenia, bipolar disorder, and oncology among others. For more information, please visit https://www.sklifescienceinc.com/innovation/#/pipeline.
